NEW YORK, Oct. 14 (GenomeWeb News) - Epoch Biosciences said today that it has reached an agreement with Millennium Pharmaceuticals for its MGB Eclipse Probe Systems for multiplexed gene expression analysis.
Epoch said it would develop, functionally test, and supply multiplexed MGB Eclipse assays to gene targets specified by Millennium.
On Oct. 6, Epoch said it had terminated a distribution agreement for the MGB Eclipse Probe Systems with Amersham Biosciences.